Avalyn Pharma AVLN
$28.40 −$0.30 (-1.05%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $28.40 0.00%
Open$28.06
Prev close$28.70
Day range$27.85 – $29.38
Volume214.3K
Market cap$1.26B
P/E (TTM)–
Dividend yield–
AVLN Stock News
Headlines matching Avalyn Pharma or the AVLN ticker, most recent first.
- Jefferies Maintains Avalyn Pharma(AVLN.US) With Buy Rating, Maintains Target Price $52
- Morgan Stanley Maintains Avalyn Pharma(AVLN.US) With Buy Rating, Raises Target Price to $57 Positive
- Analysts Offer Insights on NA Companies: Avalyn Pharma Inc (AVLN) and EquipmentShare.com, Inc. (EQPT)
- Morgan Stanley Maintains AVALYN PHARMA INC(AVLN.US) With Buy Rating, Maintains Target Price $53
- Analysts Are Bullish on These NA Stocks: MiniMed Group, Inc. (MMED), Avalyn Pharma Inc (AVLN) Positive
- Evercore Initiates AVALYN PHARMA INC(AVLN.US) With Buy Rating, Announces Target Price $51
- Jefferies Maintains AVALYN PHARMA INC(AVLN.US) With Buy Rating, Maintains Target Price $52
- Morgan Stanley Initiates AVALYN PHARMA INC(AVLN.US) With Buy Rating, Announces Target Price $53
- Jefferies Initiates AVALYN PHARMA INC(AVLN.US) With Buy Rating, Announces Target Price $52
- Avalyn Pharma(AVLN.US) 10% Shareholder Sells US$6.7 Million in Common Stock
- Earnings Flash (AVLN) Avalyn Pharma Posts Q3 Net Loss $0.67 a Share, Vs. FactSet Est of $0.59 Loss Negative
- Raymond James Initiates Avalyn Pharma(AVLN.US) With Buy Rating, Announces Target Price $60
No comments yet — be the first to weigh in on AVLN.
Sign in to join the discussion.